[Primary vascular form of pulmonary hypertension. A comprehensive comparison with a new therapeutic and resistance-computing technic].
D000083:Acetanilides / Q000627:therapeutic use; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000605:Amino Alcohols / Q000494:pharmacology; D001783:Blood Flow Velocity; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D004562:Electrocardiography; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D007457:Iodine Radioisotopes; D008297:Male; D008722:Methods; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D011652:Pulmonary Circulation / Q000187:drug effects; D011660:Pulmonary Heart Disease / Q000503:physiopathology*; D011877:Radionuclide Imaging; D012110:Reserpine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects*
D000083:Acetanilides; D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D004983:Ethanolamines; D007457:Iodine Radioisotopes; D012110:Reserpine; D010100:Oxygen
Die primär vaskuläre Form der pulmonalen Hypertonie. Ein zusammenfassender Vergleich mit einer neuen Behandlungs- und widerstandsberechnungsmethode.